{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:25:55Z","timestamp":1781843155399,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye and Vis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare the intermediate-term efficacy of PRESERFLO (PF) MicroShunt implantation with trabeculectomy (TE) in patients with primary open-angle glaucoma, focusing on longitudinal changes of functional and structural parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective comparative study included 104 eyes of 104 patients who underwent TE and 83 eyes of 83 patients that underwent PF implantation between January 2019 and December 2020, with a minimum follow-up of two years. Baseline and postoperative intraocular pressure (IOP), number of IOP-lowering medications, visual field mean defect (MD) and peripapillary retinal nerve fibre layer (RNFL) thickness measured using optical coherence tomography were assessed and compared between groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Baseline characteristics (age, sex, IOP, number of IOP-lowering medications, MD, RNFL thickness) were comparable between the two groups (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). During the two-year of follow-up, mean IOP decreased from 24.09\u2009\u00b1\u20091.15\u00a0mmHg and 21.67\u2009\u00b1\u20090.77\u00a0mmHg to 11.37\u2009\u00b1\u20091.13\u00a0mmHg (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 15.50\u2009\u00b1\u20091.54\u00a0mmHg (<jats:italic>P<\/jats:italic>\u2009=\u20090.028), and the mean number of IOP-lowering medications decreased from 3.25\u2009\u00b1\u20090.14 and 3.51\u2009\u00b1\u20090.14 to 0.53\u2009\u00b1\u20090.14 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 1.06\u2009\u00b1\u20090.43 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in the TE and PF groups, respectively. MD remained stable [\u2212\u200911.54\u2009\u00b1\u20090.93\u00a0dB and\u2009\u2212\u200911.17\u2009\u00b1\u20091.66 to\u2009\u2212\u200910.67\u2009\u00b1\u20090.91\u00a0dB (<jats:italic>P<\/jats:italic>\u2009=\u20090.226) and\u2009\u2212\u200910.40\u2009\u00b1\u20094.75\u00a0dB (<jats:italic>P<\/jats:italic>\u2009=\u20090.628) in the TE and PF groups, respectively] but RNFL thickness decreased continuously during follow-up [62.79\u2009\u00b1\u20091.94\u00a0\u00b5m and 62.62\u2009\u00b1\u20092.05\u00a0\u00b5m to 57.41\u2009\u00b1\u20091.81\u00a0\u00b5m (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and 60.22\u2009\u00b1\u20091.98\u00a0\u00b5m (<jats:italic>P<\/jats:italic>\u2009=\u20090.182) in the TE and PF groups, respectively].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>PF implantation is comparably effective in the intermediate term in lowering IOP and reducing the use of IOP-lowering medications over a two-year follow-up period. Although visual field defects were stable, RNFL continued to decrease during postoperative follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40662-023-00369-8","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T01:02:16Z","timestamp":1703120536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up study"],"prefix":"10.1186","volume":"10","author":[{"given":"Pascal Aurel","family":"Gubser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel-Benjamin","family":"Lincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael Urs","family":"H\u00e4ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Zinkernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1469-0412","authenticated-orcid":false,"given":"Jan Darius","family":"Unterlauft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"issue":"10108","key":"369_CR1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","volume":"390","author":"JB Jonas","year":"2017","unstructured":"Jonas JB, Aung T, Bourne RR, Bron AM, Ritch R, Panda-Jonas S. Glaucoma. Lancet. 2017;390(10108):2183\u201393.","journal-title":"Lancet"},{"issue":"2","key":"369_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1442-9071.1995.tb00135.x","volume":"23","author":"HA Quigley","year":"1995","unstructured":"Quigley HA. Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z J Ophthalmol. 1995;23(2):85\u201391.","journal-title":"Aust N Z J Ophthalmol"},{"key":"369_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.pbr.2015.05.005","volume":"220","author":"H Levkovitch-Verbin","year":"2015","unstructured":"Levkovitch-Verbin H. Retinal ganglion cell apoptotic pathway in glaucoma: initiating and downstream mechanisms. Prog Brain Res. 2015;220:37\u201357.","journal-title":"Prog Brain Res"},{"issue":"1","key":"369_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ophtha.2007.03.017","volume":"115","author":"MC Leske","year":"2008","unstructured":"Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B, BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85\u201393.","journal-title":"Ophthalmology"},{"issue":"18","key":"369_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901\u201311.","journal-title":"JAMA"},{"issue":"9422","key":"369_CR6","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363(9422):1711\u201320.","journal-title":"Lancet"},{"issue":"10","key":"369_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268\u201379.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"369_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121(1):48\u201356.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"369_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/ceo.13989","volume":"50","author":"RJ Casson","year":"2022","unstructured":"Casson RJ. Medical therapy for glaucoma: a review. Clin Exp Ophthalmol. 2022;50(2):198\u2013212.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"369_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/jop.2014.0067","volume":"31","author":"D Schmidl","year":"2015","unstructured":"Schmidl D, Schmetterer L, Garh\u00f6fer G, Popa-Cherecheanu A. Pharmacotherapy of glaucoma. J Ocul Pharmacol Ther. 2015;31(2):63\u201377.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"369_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2011.07.005","volume":"57","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Fudemberg SJ, Spaeth GL. The changing conceptual basis of trabeculectomy: a review of past and current surgical techniques. Surv Ophthalmol. 2012;57(1):1\u201325.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"369_CR12","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.ophtha.2013.07.049","volume":"120","author":"JF Kirwan","year":"2013","unstructured":"Kirwan JF, Lockwood AJ, Shah P, Macleod A, Broadway DC, King AJ, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120(12):2532\u20139.","journal-title":"Ophthalmology"},{"issue":"Pt 4","key":"369_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/eye.2001.152","volume":"15","author":"B Edmunds","year":"2001","unstructured":"Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. II. Variations in operative technique and outcome. Eye (Lond). 2001;15(Pt 4):441\u20138.","journal-title":"Eye (Lond)"},{"issue":"4","key":"369_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2011.09.043","volume":"119","author":"J Landers","year":"2012","unstructured":"Landers J, Martin K, Sarkies N, Bourne R, Watson P. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012;119(4):694\u2013702.","journal-title":"Ophthalmology"},{"issue":"12","key":"369_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jamaophthalmol.2013.5059","volume":"131","author":"E Rulli","year":"2013","unstructured":"Rulli E, Biagioli E, Riva I, Gambirasio G, De Simone I, Floriani I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131(12):1573\u201382.","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"369_CR16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ajo.2012.10.017","volume":"155","author":"S Zahid","year":"2013","unstructured":"Zahid S, Musch DC, Niziol LM, Lichter PR, Collaborative Initial Glaucoma Treatment Study Group. Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol. 2013;155(4):674\u201380, 80.e1.","journal-title":"Am J Ophthalmol."},{"issue":"6","key":"369_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.ajo.2015.03.001","volume":"159","author":"EA Kim","year":"2015","unstructured":"Kim EA, Law SK, Coleman AL, Nouri-Mahdavi K, Giaconi JA, Yu F, et al. Long-term bleb-related infections after trabeculectomy: incidence, risk factors, and influence of bleb revision. Am J Ophthalmol. 2015;159(6):1082\u201391.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"369_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2021.1903513","volume":"36","author":"FA Birnbaum","year":"2021","unstructured":"Birnbaum FA, Neeson C, Sol\u00e1-Del Valle D. Microinvasive glaucoma surgery: an evidence-based review. Semin Ophthalmol. 2021;36(8):772\u201386.","journal-title":"Semin Ophthalmol"},{"issue":"8","key":"369_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183142","volume":"12","author":"C Lavia","year":"2017","unstructured":"Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0183142.","journal-title":"PLoS ONE"},{"issue":"1","key":"369_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/jbm.b.33525","volume":"105","author":"L Pinchuk","year":"2017","unstructured":"Pinchuk L, Riss I, Batlle JF, Kato YP, Martin JB, Arrieta E, et al. The development of a micro-shunt made from poly(styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017;105(1):211\u201321.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"2","key":"369_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J, et al. Safety and effectiveness of the PRESERFLO\u00ae MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma. 2022;5(2):195\u2013209.","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"369_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/IJG.0000000000002178","volume":"32","author":"AM Seuthe","year":"2023","unstructured":"Seuthe AM, Erokhina M, Szurman P, Haus A. One year results of PRESERFLO\u00ae MicroShunt implantation for refractory glaucoma. J Glaucoma. 2023;32(5):414\u20139.","journal-title":"J Glaucoma"},{"issue":"4","key":"369_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ogla.2022.11.006","volume":"6","author":"L Van Lancker","year":"2023","unstructured":"Van Lancker L, Saravanan A, Abu-Bakra M, Reid K, Quijano C, Goyal S, et al. Clinical outcomes and cost analysis of PreserFlo versus trabeculectomy for glaucoma management in the United Kingdom. Ophthalmol Glaucoma. 2023;6(4):342\u201357.","journal-title":"Ophthalmol Glaucoma"},{"issue":"7","key":"369_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/IJG.0000000000002052","volume":"31","author":"M Ibarz Barber\u00e1","year":"2022","unstructured":"Ibarz Barber\u00e1 M, Mart\u00ednez-Gald\u00f3n F, Caballero-Magro E, Rodr\u00edguez-Pi\u00f1ero M, Ta\u00f1\u00e1-Rivero P. Efficacy and safety of the Preserflo Microshunt with mitomycin C for the treatment of open angle glaucoma. J Glaucoma. 2022;31(7):557\u201366.","journal-title":"J Glaucoma"},{"issue":"8","key":"369_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1136\/bjophthalmol-2021-320631","volume":"107","author":"A Tanner","year":"2023","unstructured":"Tanner A, Haddad F, Fajardo-Sanchez J, Nguyen E, Thong KX, Ah-Moye S, et al. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Br J Ophthalmol. 2023;107(8):1104\u201311.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"369_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","volume":"37","author":"R Bhayani","year":"2023","unstructured":"Bhayani R, Mart\u00ednez de la Casa JM, Figus M, Klabe K, Rabiolo A, Mercieca K. Short-term safety and efficacy of Preserflo\u2122 Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond). 2023;37(4):644\u20139.","journal-title":"Eye (Lond)"},{"issue":"1","key":"369_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vision6010012","volume":"6","author":"G Gambini","year":"2022","unstructured":"Gambini G, Carl\u00e0 MM, Giannuzzi F, Caporossi T, De Vico U, Savastano A, et al. PreserFlo\u00ae MicroShunt: an overview of this minimally invasive device for open-angle glaucoma. Vision (Basel). 2022;6(1):12.","journal-title":"Vision (Basel)"},{"key":"369_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000458483","volume":"59","author":"PT Khaw","year":"2017","unstructured":"Khaw PT, Chiang M, Shah P, Sii F, Lockwood A, Khalili A. Enhanced trabeculectomy: the moorfields safer surgery system. Glaucoma Surg. 2017;59:15\u201335.","journal-title":"Glaucoma Surg"},{"key":"369_CR29","unstructured":"Pinchuk L, Riss I, Batlle JF, Beckers H, Stalmans I. An ab externo minimally invasive aqueous shunt comprised of a novel biomaterial. Current Developments in Glaucoma Surgery and Migs: Kugler Publications; 2020. p. 181\u201392."},{"issue":"4","key":"369_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0002-9394(68)91288-9","volume":"66","author":"JE Cairns","year":"1968","unstructured":"Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673\u20139.","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"369_CR31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/bjo.2005.072884","volume":"90","author":"I Stalmans","year":"2006","unstructured":"Stalmans I, Gillis A, Lafaut AS, Zeyen T. Safe trabeculectomy technique: long term outcome. Br J Ophthalmol. 2006;90(1):44\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"369_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.eye.6700148","volume":"16","author":"B Edmunds","year":"2002","unstructured":"Edmunds B, Thompson JR, Salmon JF, Wormald RP. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond). 2002;16(3):297\u2013303.","journal-title":"Eye (Lond)"},{"issue":"3","key":"369_CR33","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2022;100(3):e779\u201390.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"369_CR34","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","volume":"128","author":"ND Baker","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, Stiles MC, Vold SD, Khatana AK, et al. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021;128(12):1710\u201321.","journal-title":"Ophthalmology"},{"issue":"3","key":"369_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ophtha.2019.10.002","volume":"127","author":"SJ Gedde","year":"2020","unstructured":"Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed IIK, et al. Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 3 years of follow-up. Ophthalmology. 2020;127(3):333\u201345.","journal-title":"Ophthalmology"},{"issue":"6","key":"369_CR36","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ophtha.2006.01.062","volume":"113","author":"H Fontana","year":"2006","unstructured":"Fontana H, Nouri-Mahdavi K, Lumba J, Ralli M, Caprioli J. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology. 2006;113(6):930\u20136.","journal-title":"Ophthalmology"},{"issue":"2","key":"369_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23(2):96\u2013104.","journal-title":"Curr Opin Ophthalmol"},{"issue":"19","key":"369_CR38","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.3390\/jcm11195840","volume":"11","author":"C Bormann","year":"2022","unstructured":"Bormann C, Busch C, Rehak M, Schmidt M, Scharenberg C, Ziemssen F, et al. Two year functional and structural changes-a comparison between trabeculectomy and XEN microstent implantation using spectral domain optical coherence tomography. J Clin Med. 2022;11(19):5840.","journal-title":"J Clin Med"},{"issue":"1","key":"369_CR39","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1038\/s41598-020-59792-9","volume":"10","author":"J Chua","year":"2020","unstructured":"Chua J, Kadziauskien\u0117 A, Wong D, A\u0161oklis R, Lesinskas E, Quang ND, et al. One year structural and functional glaucoma progression after trabeculectomy. Sci Rep. 2020;10(1):2808.","journal-title":"Sci Rep"},{"issue":"6","key":"369_CR40","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s10792-021-01840-y","volume":"41","author":"AA Demirta\u015f","year":"2021","unstructured":"Demirta\u015f AA, Karahan M, Erdem S, Aslan Kaya A, Keklik\u00e7i U. Long-term effects of trabeculectomy in primary open-angle glaucoma on segmented macular ganglion cell complex alterations. Int Ophthalmol. 2021;41(6):2249\u201363.","journal-title":"Int Ophthalmol"},{"key":"369_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2020.02.020","volume":"215","author":"MB Schlenker","year":"2020","unstructured":"Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141\u201353.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye and Vision"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40662-023-00369-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40662-023-00369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T01:02:18Z","timestamp":1703120538000},"score":1,"resource":{"primary":{"URL":"https:\/\/eandv.biomedcentral.com\/articles\/10.1186\/s40662-023-00369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["369"],"URL":"https:\/\/doi.org\/10.1186\/s40662-023-00369-8","relation":{},"ISSN":["2326-0254"],"issn-type":[{"value":"2326-0254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Commission of the Canton of Bern (BASEC-ID:ID 2022-01046). The need for participation consent was waived due to the retrospective nature of this study. Written informed consent for all performed surgical procedures was obtained from each patient prior to scheduled surgery. The study protocol was in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}